Collateral for a security interest recorded Oct 19, 2022 (Orbimed Royalty & Credit Opportunities IV, LP).
Term ended Apr 8, 2024 · Medium confidence
20-year base term ended Oct 29, 2023
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 7,718,189), so the cap could be lower.
Held by Insmed Incorporated
Filed Mar 29, 2010 as application 12/748,756 · Granted Aug 12, 2014
Base term plus 162 days of patent term adjustment (USPTO delay)
Today
Term ended Apr 8, 2024
2003
2026
Clock starts
Oct 29, 2003
Oct 29, 2003
Term ended
Apr 8, 2024
Apr 8, 2024
Granted
Aug 12, 2014
Aug 12, 2014
base term
patent term adjustment
after the term ends
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
162
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,544,369, US 7,718,189, to Apr 8, 2024. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
25
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 162 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 29, 2003, when application 10/696,389, the earliest non-provisional in its chain, was filed (this one was filed Mar 29, 2010) | Oct 29, 2023 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +162 days, USPTO patent term adjustment record | Apr 8, 2024 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,544,369, US 7,718,189) | resolves to Apr 8, 2024, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Apr 8, 2024 | Medium confidence |
This family
| US 7,544,369 | Term ended Jun 2025 | Jun 2025 |
| Application 11/023,971 | Abandoned not computed | not computed |
| US 7,718,189 | In force no later than Feb 2027 | no later than Feb 2027 |
| US 7,879,351 | In force no later than Nov 2026 | no later than Nov 2026 |
| Application PCT/US2006/027859 | PCT application no patent term | no patent term |
| Application PCT/US2007/008404 | PCT application no patent term | no patent term |
| Application 12/424,177 | Abandoned not computed | not computed |
| US 8,802,137 | this patent Apr 2024 | Apr 2024 |
8 of 25 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 5, 2011 Reel 27325, frame 401 | Transave, Inc.; Transave, LLC | Insmed Incorporated | Merger |
| Dec 5, 2011 Reel 27325, frame 936 | Boni, Lawrence; Miller, Brian S.; Malinin, Vladimir; Li, Xingong | Insmed Incorporated | Assignment of Assignor's Interest |
| Aug 7, 2013 Reel 30958, frame 277 | Boni, Lawrence T.; Miller, Brian S.; Malinin, Vladimir; Li, Xingong | Transave, Inc. | Assignment of Assignor's Interest |
| Aug 7, 2013 Reel 30959, frame 682 | Transave, LLC | Insmed Incorporated | Assignment of Assignor's Interest |
| Aug 7, 2013 Reel 30984, frame 214 | Transave, Inc. | Transave, LLC | Corrective Assignment to Correct the Name of the Assignor and the Assignee on the Cover Sheet Previously Recorded on Reel 027325 Frame 0401. Assignor(S) Hereby Confirms the Name of the Assignor Is Transave, Inc. and the Name of the Assignee Is Transave, LLC. |
| Oct 19, 2022 Reel 61727, frame 39 | Insmed Incorporated | Orbimed Royalty & Credit Opportunities IV, LP | Second Lien Patent Security Agreement |
| Oct 20, 2022 Reel 61735, frame 875 | Insmed Incorporated | Biopharma Credit PLC | Patent Security Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Note
The 162 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 7,544,369, US 7,718,189, ends no earlier than this term, so it caps nothing.
Citations
71
later US patents cite this one
That is top 10% of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.